Cambium Bio LtdASX: CMB

Date of AGM and Closing Date for Director Nominations

Sep 27, 2026 at 7:39 PM EDT · Issued by Cambium Bio Ltd via ASX

Filed with ASX · Sep 27, 2026 at 7:39 PM EDT · 2 pages · English

On 6ix: 6ix.com/news/date-of-agm-and-closing-date-for-director-nominations-39

Release

Unit 2.06/31 Lexington Drive, Bella Vista, NSW 2153 Ph: 1300 995 098 • www.cambium.bio • ABN 13 127 035 358 ASX Announcement 28 September 2026 Date of 2026 Annual General Meeting and closing date for director nominations Sydney, Australia, 28 September 2026: Cambium Bio Limited (ASX:CMB)...

Cambium Bio Ltd on 6ix

In the deck

Cambium Bio — Investor Presentation (September 2026)29 slidesSep 30, 2026

Earlier from Cambium Bio

Notification of cessation of securities - CMBSep 23
Notification regarding unquoted securities - CMBSep 22
Cambium Bio Secures A$10.85 Million to Initiate Pivotal Phase 3 Trial of Elate Ocular®, a Potential First-in-Class Biologic for Dry Eye DiseaseSep 16
Cambium Bio Secures A$10.85 Million Funding PackageSep 15
Proposed issue of securities - CMBSep 15

Later from Cambium Bio

Corporate Presentation - September 2026Sep 29
Notice of Annual General Meeting and Proxy formOct 7
Access Letter and Online Meeting GuideOct 7
Quarterly Activities/Appendix 4C Cash Flow ReportOct 28

All Cambium Bio news releases

Follow Cambium Bio into a list and get an email when it puts out news.

Follow Cambium Bio